KUREKraneShares MSCI All China Health Care Index ETF
Tracks the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.
By KraneShares · Launched 2018
Annual Cost
0.65%
#3,433 of 5,861 · average
Fund Size
$71M
#3,304 of 5,861 · mid-size
Return (1Y)Goal
-9.6%
Track Record
8 years
#1,674 of 5,861 · established
Performance
Total-return NAV · USDGrowth of $10,000
$9,265-7.3%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
Asia pacificCap
Multi cap
Strategy
Index tracking
Sector
Health careIndex tracked
MSCI China All Shares Health Care 10/40 Index
What it actually holds
By weightConcentration
Top 10 holdings = 55.2% of fundmoderately concentrated
INNOVENT BIOLOGICS, INC.
8.7%
BeOne Medicines AG
8.2%
WUXI BIOLOGICS (CAYMAN) INC.
6.6%
Akeso Inc
5.7%
WuXi AppTec Co., Ltd.
5.7%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
4.6%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
4.3%
SINO BIOPHARMACEUTICAL LIMITED
4.2%
CSPC PHARMACEUTICAL GROUP LIMITED
3.6%
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
3.6%
Asset allocation
Stocks
100.5%
By sector
Healthcare
99.3%
Consumer Defensive
0.7%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
28.3%High
Year-on-year price swings
Max drawdown
-68.5%Severe
Worst peak-to-trough loss
Sharpe (3Y)
-0.01Below average
Sortino (3Y)
-0.01Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Tracks the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.
- Strategy
- Invests primarily in foreign equity securities of Chinese companies in the healthcare sector, tracking the MSCI China All Shares Health Care 10/40 Index. Holds mid-cap and large-cap companies, using representative sampling when necessary.
- Inception date
- January 31, 2018
- Fund family
- KraneShares
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at KURE. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04